Skip to main content

Discover Our New CTMS

Trial Interactive News & Press

Monday, February 7, 2011 | 5:06 PM

New England IRB Announces FastTrack from TransPerfect

Maximizing Efficiencies in Clinical Trial Submission and Tracking

Newton, MA and New York, NY – February 7, 2011 – New England Institutional Review Board is pleased to announce the launch of a new web-based portal for IRB study management. FastTrack, powered by TransPerfect Trial Interactive, provides a secure platform for the submission, tracking, and exchange of study-related documents between New England IRB and study project teams.

FastTrack is a comprehensive system that creates efficiencies in the IRB submission and review process. It allows sponsors and CROs to submit IRB documents online, create protocol and site review status reports, access IRB documentation, and manage study access by individual documents.

FastTrack is fully configurable for communication workflow among sponsors, CROs, investigative sites, and New England IRB.

According to James Saunders, New England IRB Vice President, “We evaluated several online web portal solutions before we finally settled on Trial Interactive from TransPerfect. The Trial Interactive client services team is very responsive to any support issues on a 24/7 basis. We’re also finding that sponsors and CROs who use TransPerfect’s platform for their electronic Trial Master Files (eTMFs) or translations can jump right into using FastTrack with virtually no training. It’s a win-win solution for all.”

Michael Smyth, General Manager of TransPerfect’s Life Sciences Solutions division commented, “NEIRB is a forward-thinking organization focused on creating efficiencies for their clients, including cost savings and faster review timelines. The use of Trial Interactive allows companies like NEIRB to move further toward a paperless clinical trial solution.”

About New England IRB
New England IRB is one of the oldest national, central IRBs dedicated to ensuring the rights and welfare of research study participants. New England IRB has enjoyed full accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) since 2003 and is in good standing with FDA and OHRP. For more information, or to see a demo of FastTrack, please contact James Saunders: james.saunders@neirb.com.

About Trial Interactive
TransPerfect’s Trial Interactive solution provides a collaborative, web-based platform for clinical development that enables sponsors, CROs, IRBs, and other vendors to maintain and update clinical trial documentation in a secure online environment, adhering to global regulatory requirements. With fully searchable solutions including investigator portals, Trial Interactive streamlines study timelines and reduces the administrative burdens of global clinical trials. As part of TransPerfect’s Life Sciences division, Trial Interactive is dedicated to working with clients on a global, collaborative level, supporting a wide range of requirements including e-feasibility, study start-up, eTMF review/reconciliation, mobile applications, learning management and document management systems, investigator portals, pharmacovigilance and safety management, and endpoint adjudication. For more information on Trial Interactive, please contact info@trialinteractive.com or +1 212.400.8848, or visit www.trialinteractive.com.

About TransPerfect
TransPerfect is the world’s largest provider of language services and technology solutions for global business. From offices in over 90 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. More than 4,000 global organizations employ TransPerfect’s GlobalLink® Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.

Back to News